What The Impact Genome Project does

The Impact Genome Project is a Chicago-based for-profit company that operates the Impact Genome Registry, a platform for standardizing, measuring, verifying, and reporting the outcomes of social programs. The platform is built on an evidence-based, peer-reviewed Impact Standards taxonomy that covers 132+ common social outcomes across 12 impact areas, including Education, Public Health, Critical Human Needs, Economic Development, Arts and Culture, Sustainability & Environment, and Youth Development, all aligned with the UN Sustainable Development Goals. The Registry contains 3,900+ registered social programs, 7,000+ verified programs, and tracks $37B+ in verified social spend, providing benchmarking and cost-per-result analytics to funders and program operators.

The company monetizes through a tiered mix of subscription access to the Impact Genome Registry, an IG Membership program for nonprofits, multi-year professional services engagements for Grant Portfolio Impact Analysis, and transaction-fee revenue from Outcome Transactions, a nascent service that enables the buying and selling of verified impact credits. Go-to-market is sales-led for enterprise and government funders combined with a self-serve membership portal for nonprofits. The customer base spans corporations (CSR/ESG reporting), foundations (portfolio-level reporting), government agencies (grantee burden reduction), nonprofits (program validation), and social enterprises (impact monetization).

The company was founded in 2018 and has 11-50 employees. Its offerings and content are delivered globally via digital platforms, with no disclosed revenue or funding data. The only named customer logo is Big Brothers Big Sisters of Toronto, and the founder is Jason Saul. No AI capabilities, patents, awards, partnerships, or regulatory actions are disclosed in the available material.

Name

The Impact Genome Project

Legal name

Impact Genome

Website

https://impactgenome.org

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Chicago-based for-profit that operates the Impact Genome Registry, a standardized impact measurement platform serving corporations, foundations, government, nonprofits, and social enterprises with verified outcomes data, benchmarking, and ESG reporting tools.

Ownership category

akta.pro rank

Product category

Social Impact Measurement Software

NAICS

Computer Systems Design and Related Services (5415), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372), Services-Management Services (8741)

akta.pro primary industry

Impact Investing & Social Finance (Funds, CDFIs, Microfinance) (BPAGALAA)

akta.pro secondary industries

Impact Investment & Social Finance Programs (BPADAOAJ), Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO), Impact Investing (Intentional, Measurable Social/Environmental Outcomes) (FSAAALAC)

Keywords

• Social impact measurement
• Impact data registry
• ESG impact analytics
• Nonprofit outcome verification
• Grant portfolio benchmarking

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Impact Genome Registry Subscription: Subscription-based access to impact data and analytics tools for optimizing social impact portfolios. Targets funders including corporations, foundations, and government entities.
2. IG Membership: Membership program for nonprofits to improve program impact and increase funding chances with access to the Impact Genome Registry.
3. Grant Portfolio Impact Analysis: Professional service for measuring, reporting, and benchmarking community investment portfolio impact.
4. Outcome Transactions: Platform enabling buying, selling, and indexing of impact assets in portfolios - allowing social enterprises to sell Verified Impact Credits to ESG investors.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

The Impact Genome Project operates the Impact Genome Registry, a data and analytics platform that enables funders and program operators to measure, report, and benchmark the impact of social programs using a standardized, peer-reviewed outcomes taxonomy. The company sells subscription access to its registry of 3,900+ registered and 7,000+ verified social programs, along with membership for nonprofits and a suite of impact advisory services including portfolio analysis, impact diligence, and an outcome transactions marketplace for verified impact credits.

Product overview

The Impact Genome Project operates as a platform-plus-services organization offering a unified registry of verified social programs with accompanying analytics and membership services. The core product is the Impact Genome Registry™ Subscription, which provides access to verified impact data across 3,900+ social programs. This is complemented by Grant Portfolio Impact Analysis for funders and IG Membership for nonprofits. The services layer includes Advanced Analytics, Outcome Transactions (buying/selling verified impact credits), Portfolio Optimization, Impact Diligence™, and Impact Strategy consulting. The platform is built on evidence-based Impact Standards that verify 132+ common social outcomes aligned with UN Sustainable Development Goals.

Differentiator

Problem solved

Functional benefit

Brands

• Impact Genome Registry™: Impact data and analytics tools to optimize social impact portfolio
• Grant Portfolio Impact Analysis
• IG Membership
• Advanced Analytics
• Outcome Transactions
• Portfolio Optimization
• Impact Diligence™
• Impact Strategy

Quantifiable outcome

• 2.2 Million+ Registered Social Programs
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Sustainalytics (Morningstar): Sustainalytics is a major ESG and impact research provider acquired by Morningstar. Overlaps with Impact Genome in providing ESG/impact data to corporate and institutional buyers, but focused on corporate ESG ratings rather than nonprofit program outcome verification.
• MSCI ESG Research: MSCI is a global ESG and sustainability data provider serving institutional investors. Comparable to Impact Genome at the corporate/funder side as a source of impact and ESG data, though MSCI focuses on company-level ESG ratings rather than nonprofit program outcomes.
• Salesforce.org (Philanthropy Cloud / Nonprofit Cloud): Salesforce.org offers broad nonprofit and corporate philanthropy software that includes program management, fundraising, and reporting — overlapping with Impact Genome's nonprofit and foundation segments as part of a much wider product portfolio.

Others

• Devex: Devex provides data, news, and business intelligence on global development funding, including grant pipeline data for funders. Comparable as an information/data layer serving foundations and government agencies, though it does not verify nonprofit program outcomes.

Direct peers

• Fluxx: Fluxx is a cloud-based grants management platform built for foundations. Comparable to Impact Genome in serving philanthropic funders and offering portfolio-level reporting, with overlap in outcome-tracking and grantee management workflows.
• BlueMark: BlueMark provides independent impact verification and diligence services for impact investors, GPs, and LPs — directly comparable to Impact Genome's Verified Impact Standard and Impact Diligence™ offering, with overlap in target customers (funders) and methodology (third-party verification).
• Foundant Technologies: Foundant provides grants management, scholarship, and community foundation software for funders. Comparable to Impact Genome in serving foundations and government grantmakers, and increasingly overlapping in outcome reporting and portfolio analytics.
• Submittable: Submittable is a grants management and application review platform used by foundations and corporations. Comparable to Impact Genome in its foundation/government customer base and in standardizing parts of the grant lifecycle, though focused on application review rather than outcome verification.
• Benevity: Benevity is a corporate impact and employee-giving platform that helps companies manage CSR, volunteering, and grant programs. Comparable to Impact Genome in serving corporate CSR/ESG buyers and in aggregating nonprofit program data, though Benevity's data layer is less focused on outcome verification.
• TrueImpact: TrueImpact offers outcome measurement and reporting tools for corporations and nonprofits, including benchmarking of social programs by cost per outcome. Closely aligned with Impact Genome's Grant Portfolio Impact Analysis and IG Membership products, and serves the same funder/nonprofit buyer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/genomeimpact

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Impact Genome Project